In this study, we demonstrated a significant oncogenic role played by FTO in promoting CRC tumorigenesis by protecting CRC from ferroptotic cell death through triggering both GPX4 and SLC7A11 expression, which guard CRC from ferroptotic damage by eliminating the accumulation of lipid peroxidation. The gene discussed is GPX4; the disease is colorectal carcinoma.